The Department of Health and Human Services (HHS) has found itself under intense scrutiny, with reports emerging of significant internal shake-ups and new oversight controls being implemented. This comes as the leadership of Secretary Robert F. Kennedy Jr. faces mounting criticism for a series of controversial decisions and policy missteps, particularly concerning vaccine stances. These issues are now being viewed as a potential political liability for Republican candidates as they approach the upcoming midterm elections.
While President Trump has publicly expressed support for his HHS Secretary, insiders within the White House are reportedly growing increasingly concerned. Some officials, who never fully backed Kennedy’s prominent position, are alarmed by what they perceive as erratic leadership and policy blunders that could negatively impact GOP candidates. According to reporting from The Wall Street Journal, Kennedy’s standing among some HHS staff has reached an all-time low.
Internal Repercussions and Policy Reversals
The concerns extend to the highest levels, with Trump aides reportedly taking direct control over Kennedy’s department. This decisive action follows internal polling that revealed widespread unpopularity of his vaccine skepticism and other health-related initiatives. Despite an initial assurance from President Trump that Kennedy could “go wild on health,” administration officials have expressed growing frustration with what they describe as a string of significant errors.
Kennedy’s influence within HHS has reportedly dwindled following multiple setbacks to his “Make America Healthy Again” agenda. However, those familiar with his relationship with the President suggest that he continues to enjoy Trump’s personal favour.
A Series of Setbacks
The challenges facing the HHS under Kennedy’s leadership have been significant, prompting a substantial overhaul of the department’s structure. Key incidents contributing to this turmoil include:
- Measles Outbreak Response: Kennedy faced criticism for what was perceived as a slow and inadequate initial response to a measles outbreak in Texas. This raised concerns about the department’s preparedness and effectiveness in managing public health crises.
- Abortion Pill Approval: Officials within the Food and Drug Administration (FDA), a key agency under HHS, reportedly surprised the department with an unexpected approval of a generic abortion pill. This decision generated considerable debate and highlighted potential communication breakdowns within the administration.
- Mental Health and Substance Abuse Program Cuts: In January, the White House was reportedly blindsided by controversial grant cuts to vital mental health and substance abuse programs, initiated by Kennedy. The backlash from Capitol Hill was swift and severe, forcing the department to reverse these cuts.
- FDA Under Scrutiny: The FDA has been a consistent source of operational challenges and controversy during Kennedy’s tenure, leading to ongoing concerns about its management and decision-making processes.
Efforts to Restore Order
In a bid to address the escalating chaos and restore functionality to the beleaguered department, the White House has brought in external expertise. Brad Smith, identified as a DOGE operative, has been engaged to conduct a thorough audit of HHS operations. His mandate includes identifying areas of failure and recommending strategic changes.
Smith’s recommendations have reportedly focused on implementing structural changes designed to mitigate internal conflicts and enhance the overall effectiveness of the department. This intervention underscores a perceived loss of confidence from Trump officials in Kennedy’s ability to effectively lead one of the government’s largest and most critical agencies, even as the President publicly reaffirms his support for his embattled Cabinet member.
